Latest news
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors - Investing News NetworkInvesting News Network · Thu, 06 Aug 2026 22:13:08 GMTRenovoRx’s RenovoCath used in sarcoma treatment for first time - Investing.comInvesting.com · Thu, 06 Aug 2026 14:56:50 GMTRenovoRx Announces First Commercial Clinical Use Of RenovoCath In Sarcoma Patient Treatment - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 12:30:00 GMTRenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET - The Manila TimesThe Manila Times · Wed, 29 Jul 2026 12:43:22 GMT